Market Sensitive News

U.S. Stocks Close Roughly Flat After U.S., China Reach Trade Deal

U.S., China Reach Agreement On Phase One Trade Deal

U.S. Business Inventories Rise In Line With Estimates In October

Labor Board Rules In Favor Of McDonald's In Union Case By Franchise Workers

Bitcoin Looking Weaker

Washington State Seeks To Ban 'assault Weapons' Sale

Binance Partners Paxful To Enable BTC Purchases In 167 Fiat Currencies

U.S. Import Prices Rise 0.2% In November, In Line With Estimates

U.S. Retail Sales Growth Falls Well Short Of Estimates In November

Russia Central Bank Signals More Rate Cuts Ahead

Facebook Stock Down On News Of Possible FTC Injunction Against Combining Apps

Pepsi Launches New Coffee-infused Cola 'Pepsi Café'

Axel Springer: KKR's Tender Offer Receives Last Outstanding Merger Clearance

Top Gainers: THOR Acquired, FTSV Up On Magrolimab Data, Investors Believe FATE

Globus Medical's (GMED) Got A Spine...

APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges

Maren Morris Shows Off Baby Bump In Bikini Photo To Mark 2nd Trimester

Healthcare IPOs That Delivered Solid Returns In 2019

Roche Gets CE Mark For Its Accu-Chek SugarView App - Quick Facts

U.S. Consumer Prices Rise Slightly More Than Expected In November

Are These Biotech Companies Buyout Candidates? Deal Or No Deal?

FDA Panel Says No To CORV, ITRM For Sure Has Disappointed, ELOX, XERS On Watch

UK Inflation Expectations Weaken In November: BoE Survey

Federal Reserve Leaves Rates Unchanged After Three Straight Cuts

Sanofi To Discontinue Research In Diabetes And Cardiovascular

Ifo Says Free-Fall In German Industry Stopped

Air France KLM Nov. Total Group Traffic Up 3.6% - Quick Facts

Euro Mixed Ahead Of German Trade Data

Swiss Jobless Rate Steady At 2.3%

Franc Little Changed Following Swiss Unemployment Data

Franc Mixed Ahead Of Swiss Unemployment Data

Roche Announces Changes In Board Of Directors

Sanofi Agrees To Buy Synthorx For $2.5 Bln - Quick Facts

European Shares Poised For A Weak Start

Portola Pharma Presents News Phase IIa Study Of Cerdulatinib

Ireland's Construction Sector Conditions Deteriorate In November